Hesperidin and heart markers

What 2 graded rows on hesperidin agree on for heart markers, and where they differ. Counted side by side, never averaged.

Consensus finder Rows from the Hesperidin page, reviewed Oct 21, 2026 How it decides

What the rows agree on

Each block and row is one graded row from the Hesperidin page, with its PubMed record.

Supplement

Hesperidin Choose another

2 rows · 2,991 people

Split. 1 row found no difference and 1 had mixed results.

No difference or mixed

Improved

Each block is one evidence row, sized by how many people it enrolled, with its grade inside. Outlined: mixed results.

From the rows

The best-graded row, grade C, is a meta-analysis of 2,414 people (2024) and reported mixed results.

The rows run from 577 to 2,414 people, published from 2019 to 2024: 2 pooled reviews and 0 single studies.

1 no difference · 1 mixed

Grade CCholesterol, triglycerides and blood pressure · No difference
Meta-analysis, 10 studies · n 577 · 2019 · Adults in 10 randomized trials
Varied across trials · Varied across trials
Hesperidin had no effect on total, LDL or HDL cholesterol, triglycerides, or systolic and diastolic blood pressure compared with control.
Row on the Hesperidin page · PubMed 30632207 (opens PubMed)
Grade CCholesterol and blood pressure · Mixed
Meta-analysis, 9 studies · n 2,414 · 2024 · Healthy people and people with cardiometabolic conditions in 9 trials
Varied across trials · Varied across trials
Hesperidin lowered LDL, total cholesterol and triglycerides versus placebo or control, with no change in systolic or diastolic blood pressure or HDL; heterogeneity was high for LDL and total cholesterol.
Row on the Hesperidin page · PubMed 38462779 (opens PubMed)